About Adenylyl cyclase-associated protein 2
Adenylyl cyclase-associated protein 2 (CAP2) is a protein
from Homo sapiens identified by UniProt accession
P40123, 477 residues long.
MolForge cross-references it against 0 known binders and
300 disease associations.
Target properties
| Protein name | Adenylyl cyclase-associated protein 2 |
| UniProt accession | P40123 |
| Gene | CAP2 |
| Organism | Homo sapiens |
| Length | 477 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (300)
Diseases linked to this target (Open Targets).
- cardiomyopathy, dilated, 2I · score 0.48
- familial isolated dilated cardiomyopathy · score 0.38
- testosterone measurement · score 0.38
- hemorrhoid · score 0.36
- cutaneous melanoma · score 0.13
- hypertrophic cardiomyopathy · score 0.08
- Romano-Ward syndrome · score 0.08
- Brugada syndrome · score 0.07
- dilated cardiomyopathy · score 0.07
- familial atrial fibrillation · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P40123-F1 | alphafold | PREDICTED | 82.82 | — |
Amino-acid sequence (477 residues)
MANMQGLVER LERAVSRLES LSAESHRPPG NCGEVNGVIA GVAPSVEAFD KLMDSMVAEF LKNSRILAGD VETHAEMVHS AFQAQRAFLL MASQYQQPHE NDVAALLKPI SEKIQEIQTF RERNRGSNMF NHLSAVSESI PALGWIAVSP KPGPYVKEMN DAATFYTNRV LKDYKHSDLR HVDWVKSYLN IWSELQAYIK EHHTTGLTWS KTGPVASTVS AFSVLSSGPG LPPPPPPLPP PGPPPLFENE GKKEESSPSR SALFAQLNQG EAITKGLRHV TDDQKTYKNP SLRAQGGQTQ SPTKSHTPSP TSPKSYPSQK HAPVLELEGK KWRVEYQEDR NDLVISETEL KQVAYIFKCE KSTIQIKGKV NSIIIDNCKK LGLVFDNVVG IVEVINSQDI QIQVMGRVPT ISINKTEGCH IYLSEDALDC EIVSAKSSEM NILIPQDGDY REFPIPEQFK TAWDGSKLIT EPAEIMA
Explore Adenylyl cyclase-associated protein 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets